Market Overview

UPDATE: Morgan Stanley Cuts PT to $42 on MetLife Following Guidance

Share:
Related MET
Watch These 8 Huge Put Purchases In Wednesday Trade
4 Stocks Moving In Tuesday's After-Hours Session: Earnings, Corrections, Asset Sales
Financials lower by more than 4% post-Brexit (Seeking Alpha)

Morgan Stanley reiterated its Overweight rating on MetLife (NYSE: MET) but lowered its price target from $44 to $42.

Morgan Stanley noted, "MetLife's guidance was modestly disappointing, with both EPS and capital expectations running somewhat below our expectations. That said, their guidance is typically conservative (they typically hit at least the high end), and even with lowered numbers, the valuation multiple on stock is very low."

MetLife closed at $33.61 on Wednesday.

Latest Ratings for MET

DateFirmActionFromTo
May 2016JP MorganMaintainsOverweight
Feb 2016FBR CapitalMaintainsOutperform
Feb 2016BarclaysMaintainsOverweight

View More Analyst Ratings for MET
View the Latest Analyst Ratings

Posted-In: Morgan StanleyAnalyst Color Price Target Intraday Update Analyst Ratings

 

Related Articles (MET)

View Comments and Join the Discussion!